List of largest biomedical companies by revenue

The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least 10 billion USD dollars, ranked by their revenue in the respective financial year.

It does not include biotechnology companies that are now owned by, or form a part of, larger pharmaceutical groups.

Ranking by revenueEdit

The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD dollars. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the preceding year. Red cells indicate those years where there has been a decrease.

Rank Chg Company Country Traded on 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
1   Johnson & Johnson   USA NYSEJNJ 93.78[1] 82.59[1] 82.06[2] 81.60[3] 76.50[4] 71.89[5] 70.10[6] 74.30[7] 71.31[8] 67.20[9]
3   Sinopharm   CHN SEHK1099 81.77[10] 71.75[11] 60.18[12] 48.75[13] 43.63[14] 36.56[15] 32.36[16] 28.32[17] 23.61[18] 19.31[19]
2   6 Pfizer   USA NYSEPFE 81.29[20] 41.91[21] 41.17[21] 40.83[21] 52.54[22] 52.82[23] 48.85[24] 49.61[25] 51.58[26] 58.99[27]
4   1 Roche   SUI SIXROG 67.83[28] 62.99[28] 63.85[29] 56.86[30] 57.37[31] 50.11[32] 47.70[33] 49.86[34] 48.53[35] 47.80[36]
5   2 AbbVie   USA NYSEABBV 56.20[37] 45.80[37] 33.27[38] 32.75[39] 28.22[40] 25.56[41] 22.82[42] 19.96[43] 18.79[44]
6   2 Novartis   SUI NYSENVS 51.63[45] 48.66[45] 47.45[46] 44.75[47] 49.11[48] 48.52[49] 49.41[50] 58.00[51] 57.36[52] 56.67[53]
7   2 Bayer   GER FWBBAYN 49.46[54] 47.40[55] 48.02[56] 45.06[57] 37.94[58] 25.27[59] 24.09[60] 25.47[61] 24.17[62] 24.30[63]
8   2 Merck & Co.   USA NYSEMRK 48.70[64] 41.52[64] 46.84[65] 42.30[66] 40.10[67] 39.80[68] 39.50[69] 42.24[70] 44.03[71] 47.27[72]
9   3 GlaxoSmithKline   GBR LSEGSK 46.91[73] 46.17[74] 43.92[75] 43.14[76] 42.05[77] 34.79[78] 29.84[79] 37.96[80] 41.61[81] 39.93[82]
10   2 Bristol Myers Squibb   USA NasdaqBMY 46.39[83] 42.52[83] 26.15[84] 22.56[85] 20.80[86] 19.43[87] 16.56[88] 15.88[89] 16.39[90] 17.62[91]
11   Sanofi   FRA NYSESNY 43.24[92] 41.27[92] 39.28[93] 39.07[94] 42.91[95] 36.57[96] 36.73[97] 43.07[98] 42.08[99] 46.41[100]
12   Abbott Laboratories   USA NasdaqABT 43.08[101] 34.61[102] 31.90[103] 30.60[104] 27.39[105] 20.85[106] 20.41[107] 20.25[108] 21.85[109] 39.87[110]
13   Takeda Pharmaceutical   JPN TYO: 4502 29.31[111] 27.76[112] 31.17[113] 19.10[114] 16.70[115] 15.96[116] 14.93 16.84 17.36 18.91
14   AstraZeneca   GBR
  SWE
LSEAZN 37.42[117] 26.62[118] 24.38[119] 22.09[120] 22.47[121] 23.00[122] 24.71[123] 26.10[124] 25.71[125] 27.97[126]
15   2 Eli Lilly & Co   USA NYSELLY 28.32[127] 24.54[128] 22.32[129] 21.49[130] 22.90[131] 21.22[132] 20.00[133] 19.62[134] 23.11[135] 22.60[136]
16   Gilead Sciences   USA NasdaqGILD 27.31[137] 24.69[137] 22.45[138] 22.13[139] 25.70[140] 30.39[140] 32.15[140] 24.47[140] 10.80[140] 9.70[140]
17   2 Amgen   USA NasdaqAMGN 25.98[141] 25.42[142] 23.40[143] 23.70[144] 22.80[145] 22.99[146] 21.66[147] 20.06[148] 18.68[149] 17.30[150]
18   Boehringer Ingelheim   GER Private 22.40[151] 21.75[151] 21.67[152] 17.54[153] 16.41[153] 17.70[153] 18.68[153] 18.89[153]
19   1 Novo Nordisk   DEN NYSENVO 21.66[154] 19.52[154] 18.30[155] 6.99[156] 18.77[157] 16.61[158] 16.06[159] 15.83[160] 14.88[161] 13.48[162]
20   1 Merck Group   GER ETR: MRK 21.40[163] 20.08[164] 18.25[165] 16.48[166] 18.70[167] 16.62[168] 14.25[169] 15.29[170] 14.73[167] 14.36[167]
21   2 Siemens Healthineers   GER FWBSHL 20.61[171] 16.56[171] 16.62[172] 15.37[173] 16.56[174] 14.25[174] 14.06[174]
22   Viatris   USA NasdaqVTRS 17.89[175] 11.95[175]
23   1 GE Healthcare   USA Subsidiary of GE 17.73[176] 18.01[177] 19.94[178] 19.78[179] 19.02[180] 18.21[181] 17.64[182] 18.30[183] 18.20[184]
24   4 Regeneron Pharmaceuticals   USA NasdaqREGN 16.07[185] 8.50[185] 7.86[186] 6.71[186] 5.87[186] 4.86[187] 4.10[188] 2.82[188] 2.10[188] 1.38[188]
25   2 Teva Pharmaceuticals   ISR NasdaqTEVA 15.88[189] 16.66[190] 16.89[191] 18.90[192] 22.40[193] 21.90[194] 20.00[195] 20.27[196] 20.31[197] 18.31[198]
26   Baxter International   USA NYSEBAX 12.778[199] 11.63[200] 11.36[200] 11.13[201] 10.56[201] 10.16[202] 9.97[203] 10.72[204] 14.97[205] 14.19[206]
27   2 Biogen   USA NasdaqBIIB 10.98[207] 13.44[207] 14.38[208] 13.45[209] 12.30[210] 11.40[211] 10.80[212] 9.70[213] 6.90[214] 5.50[215]
28   1 Astellas Pharma   JPN TYO: 4503 10.85[216] 11.29[216] 12.27[217] 12.07 12.63 11.48 10.49 9.25 8.92

See alsoEdit

ReferencesEdit

  1. ^ a b https://johnsonandjohnson.gcs-web.com/static-files/5db7df36-78aa-4769-84d4-a49cb3a273ba[bare URL PDF]
  2. ^ "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results: | BioSpace".
  3. ^ "Johnson & Johnson Reports 2018 Fourth-Quarter Results". Content Lab - U.S.
  4. ^ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  5. ^ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  6. ^ "Johnson & Johnson Reports 2015 Fourth-Quarter Results". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
  7. ^ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  8. ^ "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  9. ^ "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results".
  10. ^ "Sinopharm (1099.HK) - Revenue". companiesmarketcap.com. Retrieved 2022-04-17.
  11. ^ https://media-sinopharm.todayir.com/2021042308080224799730699_en.pdf[bare URL PDF]
  12. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2020-06-27. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  13. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-06. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  14. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  15. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  16. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  17. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  18. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  19. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  20. ^ https://s28.q4cdn.com/781576035/files/doc_financials/2021/q4/Q4-2021-PFE-Earnings-Release.pdf[bare URL PDF]
  21. ^ a b c https://s28.q4cdn.com/781576035/files/doc_financials/2020/AR/PFE-2020-Form-10K-FINAL.pdf[bare URL PDF]
  22. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf[bare URL PDF]
  23. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf[bare URL PDF]
  24. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf[bare URL PDF]
  25. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf[bare URL PDF]
  26. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf[bare URL PDF]
  27. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf[bare URL PDF]
  28. ^ a b https://www.roche.com/investors/updates/inv-update-2022-02-03.htm[bare URL]
  29. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2020-01-31. Retrieved 2020-01-31.{{cite web}}: CS1 maint: archived copy as title (link)
  30. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-07. Retrieved 2019-02-06.{{cite web}}: CS1 maint: archived copy as title (link)
  31. ^ "Roche reports good results in 2017". www.roche.com.
  32. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  33. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-01-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  34. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-03. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  35. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-03. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  36. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2016-12-02. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  37. ^ a b https://investors.abbvie.com/static-files/4805c635-ab17-4c3f-94dd-dc9bf18fbf8c[bare URL PDF]
  38. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results".
  39. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  40. ^ "Financial Release - AbbVie". investors.abbvie.com.
  41. ^ "Financial Release - AbbVie". investors.abbvie.com.
  42. ^ "Financial Release - AbbVie". investors.abbvie.com.
  43. ^ "Financial Release - AbbVie". investors.abbvie.com.
  44. ^ "Financial Release - AbbVie". investors.abbvie.com.
  45. ^ a b https://www.novartis.com/sites/novartis_com/files/q4-2021-media-release-en.pdf[bare URL PDF]
  46. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf[bare URL PDF]
  47. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf[bare URL PDF]
  48. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  49. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf[bare URL PDF]
  50. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf[bare URL PDF]
  51. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf[bare URL PDF]
  52. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf[bare URL PDF]
  53. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf[bare URL PDF]
  54. ^ https://www.bayer.com/sites/default/files/2022-03/Bayer-Annual-Report-2021.pdf[bare URL PDF]
  55. ^ https://www.bayer.com/sites/default/files/2021-02/Bayer-Annual-Report-2020.pdf[bare URL PDF]
  56. ^ "Bayer AG Annual Report 2019" (PDF). www.bayer.com.
  57. ^ "Bayer's Annual Report 2018". www.annualreport2018.bayer.com.
  58. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-03-01. Retrieved 2018-02-28.{{cite web}}: CS1 maint: archived copy as title (link)
  59. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-07-18. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  60. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-06-24. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  61. ^ AG, Bayer. "Bayer – Global Home". www.bayer.com.
  62. ^ https://www.bayer.com/en/ar-2013.pdfx[bare URL]
  63. ^ https://www.bayer.com/en/ar-2012.pdfx[bare URL]
  64. ^ a b "Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results".
  65. ^ "Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results".
  66. ^ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  67. ^ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket". CNBC.
  68. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf[bare URL PDF]
  69. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf[bare URL PDF]
  70. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf[bare URL PDF]
  71. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf[bare URL PDF]
  72. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf[bare URL PDF]
  73. ^ https://www.gsk.com/media/7383/fy-2021-us-dollar-translation.pdf[bare URL PDF]
  74. ^ https://www.gsk.com/media/6662/annual-report-2020.pdf[bare URL PDF]
  75. ^ https://www.gsk.com/media/5820/fy-2019-results-announcement.pdf[bare URL PDF]
  76. ^ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  77. ^ https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf[bare URL PDF]
  78. ^ https://www.gsk.com/media/3609/annual-report-2016.pdf[bare URL PDF]
  79. ^ https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf[bare URL PDF]
  80. ^ https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf[bare URL PDF]
  81. ^ https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf[bare URL PDF]
  82. ^ https://www.gsk.com/media/2694/annual-report-2012.pdf[bare URL PDF]
  83. ^ a b https://s21.q4cdn.com/104148044/files/doc_financials/quarterly_reports/2021/BMY-Q42021-Earnings-Press-Release.pdf[bare URL PDF]
  84. ^ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79[dead link]
  85. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  86. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  87. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  88. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  89. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  90. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
  91. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf[bare URL PDF]
  92. ^ a b https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/common/docs/investors/2022_02_04_Sanofi_Q4_FY_2021_iPDF-v3.pdf?la=en[bare URL PDF]
  93. ^ "Fourth quarter and full year 2019 results - Sanofi".
  94. ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560[bare URL PDF]
  95. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-09. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
  96. ^ https://en.sanofi.com/Images/49288_20-F_2016.pdf[bare URL PDF]
  97. ^ https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf[bare URL PDF]
  98. ^ https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf[bare URL PDF]
  99. ^ https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf[bare URL PDF]
  100. ^ https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf[bare URL PDF]
  101. ^ "Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast".
  102. ^ https://www.abbottinvestor.com/static-files/52cadf21-4090-40fd-9857-fa58e1e25949[bare URL PDF]
  103. ^ "Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020".
  104. ^ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  105. ^ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  106. ^ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  107. ^ "Abbott Reports Fourth-Quarter 2015 Results".
  108. ^ "Abbott Reports Fourth-Quarter 2014 Results".
  109. ^ Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
  110. ^ "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
  111. ^ "Takeda quarterly financial report" (PDF). Retrieved June 30, 2022.{{cite web}}: CS1 maint: url-status (link)
  112. ^ https://www.takeda.com/499b8f/siteassets/system/investors/quarterly-announcements/fy2020/qr2020_q4_qfr_en.pdf[bare URL PDF]
  113. ^ "Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum".
  114. ^ "Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance".
  115. ^ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  116. ^ "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).{{cite web}}: CS1 maint: url-status (link)
  117. ^ https://www.astrazeneca.com/content/dam/az/PDF/2021/full-year/Full-year-2021-results-announcement.pdf[bare URL PDF]
  118. ^ https://www.astrazeneca.com/content/dam/az/PDF/2020/full-year/Full-year_2020_results_announcement.pdf[bare URL PDF]
  119. ^ https://www.astrazeneca.com/content/dam/az/PDF/2019/full-year/Full-year_and_Q4_2019_results_announcement.pdf[bare URL PDF]
  120. ^ https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf[bare URL PDF]
  121. ^ https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf[bare URL PDF]
  122. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-03. Retrieved 2018-02-02.{{cite web}}: CS1 maint: archived copy as title (link)
  123. ^ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  124. ^ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  125. ^ "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
  126. ^ "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
  127. ^ https://investor.lilly.com/static-files/8f2fb9cc-d123-4baf-ace2-23cef51ce0f0[bare URL PDF]
  128. ^ https://investor.lilly.com/static-files/c03e912c-c3fd-49b4-b383-fb0debe5b2f3[bare URL PDF]
  129. ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition".
  130. ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  131. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  132. ^ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  133. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  134. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  135. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  136. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  137. ^ a b https://investors.gilead.com/static-files/107ab0e3-735c-4760-882f-c3647ea97ce2[bare URL PDF]
  138. ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results".
  139. ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  140. ^ a b c d e f "Investor Overview". Gilead Sciences.
  141. ^ https://investors.amgen.com/static-files/cc04ca13-faef-4672-a85a-3fd7c1df3c35[bare URL PDF]
  142. ^ https://investors.amgen.com/static-files/c1b90d85-8945-4d11-8d1c-5ddc343fb699[bare URL PDF]
  143. ^ "Amgen Reports Fourth Quarter and Full Year 2019 Financial Results".
  144. ^ "Amgen - Investors - Press Release". investors.amgen.com.
  145. ^ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  146. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1[bare URL]
  147. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1[bare URL]
  148. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1[bare URL]
  149. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1[bare URL]
  150. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1[bare URL]
  151. ^ a b https://www.boehringer-ingelheim.com/sites/default/files/ARPC/AR_2020/Boehringer-Ingelheim_Summary_Report_2020.pdf[bare URL PDF]
  152. ^ www.boehringer-ingelheim.com https://www.boehringer-ingelheim.com/corporate-profile/our-company/financial-highlights. {{cite web}}: Missing or empty |title= (help)
  153. ^ a b c d e "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
  154. ^ a b https://www.novonordisk.com/content/dam/nncorp/global/en/investors/irmaterial/annual_report/2022/novo-nordisk-annual-report-2021.pdf[bare URL PDF]
  155. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-23. Retrieved 2020-02-12.{{cite web}}: CS1 maint: archived copy as title (link)
  156. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-22. Retrieved 2019-02-21.{{cite web}}: CS1 maint: archived copy as title (link)
  157. ^ "News details". www.novonordisk.com. Archived from the original on 2018-02-02. Retrieved 2018-02-01.
  158. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-03-22. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  159. ^ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  160. ^ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  161. ^ Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
  162. ^ Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
  163. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2021-q4/en/2021-Q4-Report-EN.pdf[bare URL PDF]
  164. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2020-q4/en/2020-Q4-Report-EN.pdf[bare URL PDF]
  165. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2019-q4/en/2019-Q4-Report-EN.pdf[bare URL PDF]
  166. ^ "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany". www.emdgroup.com.
  167. ^ a b c "404 page - EMD Group". www.emdgroup.com. Archived from the original on 2019-02-08. Retrieved 2019-02-09. {{cite web}}: Cite uses generic title (help)
  168. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-06-19. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
  169. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-05-30. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
  170. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2018-05-29.{{cite web}}: CS1 maint: archived copy as title (link)
  171. ^ a b https://cdn0.scrvt.com/0e46935d037de4ec3888566275864b37/df1896911b345f04/bc8ba64c5954/Siemens_Healthineers_Annual-Report_2021.pdf[bare URL PDF]
  172. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000006835562/12e08501046c/Siemens-Healthineers-Annual-Report-2019.pdf[bare URL PDF]
  173. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000005904947/ef806566e5ee/Annual-Report-2018.pdf[bare URL PDF]
  174. ^ a b c https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf[bare URL PDF]
  175. ^ a b "Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results; Issues 2022 Financial Guidance; Completes Comprehensive Strategic Review; Unveils Plan to Reshape the Company for the Future; Announces Combination of its Biosimilars Portfolio with Biocon Biologics in Exchange for up to $3.335 Billion Representing an Attractive Multiple to Viatris of 16.5x the Company's Biosimilars 2022E Adjusted EBITDA(1), the First in a Series of Expected Initiatives Anticipated to Unlock up to an Add | Viatris".
  176. ^ https://www.ge.com/sites/default/files/ge_webcast_presentation_01252022.pdf[bare URL PDF]
  177. ^ https://www.ge.com/sites/default/files/GE_AR20_AnnualLetterToShareholders.pdf[bare URL PDF]
  178. ^ "General Electric Healthcare segment revenue 2008-2020".
  179. ^ "General Electric Healthcare segment revenue 2008-2020".
  180. ^ "General Electric Healthcare segment revenue 2008-2020".
  181. ^ "General Electric Healthcare segment revenue 2008-2020".
  182. ^ "General Electric Healthcare segment revenue 2008-2020".
  183. ^ "General Electric Healthcare segment revenue 2008-2020".
  184. ^ "General Electric Healthcare segment revenue 2008-2020".
  185. ^ a b https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2021-financial[bare URL]
  186. ^ a b c https://investor.regeneron.com/static-files/bc3a2029-09e7-4064-95d6-8f5a2094e161[bare URL PDF]
  187. ^ https://investor.regeneron.com/static-files/04bf9c6c-c0ed-4dcb-ae8c-8c6da6c08d61[bare URL PDF]
  188. ^ a b c d https://investor.regeneron.com/static-files/0f20ed34-4570-40e9-8bab-d769e8e3fcab[bare URL PDF]
  189. ^ https://s24.q4cdn.com/720828402/files/doc_financials/2021/q4/Press-Release-Q4-2021.pdf[bare URL PDF]
  190. ^ https://s24.q4cdn.com/720828402/files/doc_financials/2020/q4/FY2020_10K_Feb.10.2021.pdf[bare URL PDF]
  191. ^ "Teva Reports Fourth Quarter and Full Year 2019 Financial Results".
  192. ^ https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf[bare URL PDF]
  193. ^ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results". 8 February 2018.
  194. ^ "Archived copy". Archived from the original on 2018-02-03. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
  195. ^ "Archived copy". Archived from the original on 2018-09-15. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
  196. ^ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  197. ^ "Archived copy". Archived from the original on 2018-09-15. Retrieved 2018-02-08.{{cite web}}: CS1 maint: archived copy as title (link)
  198. ^ "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
  199. ^ https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2022/Baxter_Reports_Fourth-Quarter_and_Full-Year_2021_Results_Schedules.pdf[bare URL PDF]
  200. ^ a b https://s22.q4cdn.com/911189824/files/doc_financials/2020/ar/938b4abc-cc88-48af-83ef-8b67633f01af.pdf[bare URL PDF]
  201. ^ a b https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2018/q4/Q4-2018-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf[bare URL PDF]
  202. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf[bare URL PDF]
  203. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf[bare URL PDF]
  204. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf[bare URL PDF]
  205. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf[bare URL PDF]
  206. ^ https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2012/Reclassified-Sales-Final.pdf[bare URL PDF]
  207. ^ a b https://investors.biogen.com/static-files/e483fbec-6adb-4bfd-a2c0-e48d488a3256[bare URL PDF]
  208. ^ https://investors.biogen.com/static-files/ce31eed8-8862-4bec-a63f-77c0fd6e15a1[bare URL PDF]
  209. ^ http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e[bare URL PDF]
  210. ^ "Biogen's Spinraza: Great Launch, Rough Ride". Bloomberg.com. 25 January 2018 – via www.bloomberg.com.
  211. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-11-18. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  212. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  213. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2015-10-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  214. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2017-07-13. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  215. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2015-11-06. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  216. ^ a b https://www.astellas.com/jp/system/files/astellas_ar2021_en_20211126.pdf[bare URL PDF]
  217. ^ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.